Health2 years ago
Glenmark becomes the First Pharmaceutical Company to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults
‐ Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg). ‐ This anti-diabetic medication will be marketed under brand name LOBG....
